Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002389 |
---|---|
Receipt number | R000002935 |
Scientific Title | Comprehensive study to examine the effects of omalizumab in patients with bronchial asthma |
Date of disclosure of the study information | 2009/08/26 |
Last modified on | 2023/02/28 22:24:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/08/26 20:06:17 | ||
2 | Update | 2009/11/16 11:13:30 | Recruitment status |
|
3 | Update | 2010/02/07 13:31:41 | Email1 |
|
4 | Update | 2010/08/29 09:57:59 | Key secondary outcomes Key secondary outcomes |
|
5 | Update | 2011/08/26 20:41:23 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2012/02/19 14:17:21 | Last name of lead principal investigator Last name of lead principal investigator |
|
7 | Update | 2012/02/19 14:18:08 | Last follow-up date |
|
8 | Update | 2012/02/27 15:14:05 | Last follow-up date |
|
9 | Update | 2012/12/24 13:17:48 | Organization Address Co-sponsor Co-sponsor Institutions |
|
10 | Update | 2013/02/26 21:08:40 | Co-sponsor Co-sponsor |
|
11 | Update | 2014/03/31 03:47:18 | Email |
|
12 | Update | 2014/03/31 03:51:40 | Recruitment status |
|
13 | Update | 2018/03/18 19:16:04 | Control |
|
14 | Update | 2018/03/18 19:18:33 | Name of primary person or sponsor Organization |
|
15 | Update | 2018/03/18 19:23:36 | Recruitment status Publication of results |
|
16 | Update | 2023/02/28 22:22:41 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Address Address Tel |
|
17 | Update | 2023/02/28 22:24:39 | Recruitment status Date of IRB |